Crespo Blas Coll, insider filing for GPCR
Crespo Blas Coll, reporting
Every EDGAR filing for Structure Therapeutics Inc. (GPCR), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 9)
No open-market insider buys in the last 30 days.
Also: 1 grant or exercise.
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Crespo Blas Coll, insider filing for GPCR
Crespo Blas Coll, reporting
Crespo Blas Coll, planned sale of GPCR shares
Crespo Blas Coll, reporting
Xichen Lin, insider filing for GPCR
Xichen Lin, reporting
Xichen Lin, insider filing for GPCR
Xichen Lin, reporting
John Joseph Berrios, insider filing for GPCR
John Joseph Berrios, reporting
Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
Xichen Lin, insider filing for GPCR
Xichen Lin, reporting
FMR LLC, insider filing for GPCR
FMR LLC, reporting
Xichen Lin, insider filing for GPCR
Xichen Lin, reporting
Xichen Lin, insider filing for GPCR
Xichen Lin, reporting
Xichen Lin, planned sale of GPCR shares
Xichen Lin, reporting
Daniel G Welch, insider filing for GPCR
Daniel G Welch, reporting
Matthew Lang, insider filing for GPCR
Matthew Lang, reporting
FMR LLC, insider filing for GPCR
FMR LLC, reporting
Xichen Lin, insider filing for GPCR
Xichen Lin, reporting
Ashley Hall, insider filing for GPCR
Ashley Hall, reporting
Ownership stake disclosure by BIOTECHNOLOGY VALUE FUND L P (amended)
BIOTECHNOLOGY VALUE FUND L P, filed by
Ownership stake disclosure by Deep Track Capital, LP (amended)
Deep Track Capital, LP, filed by
Ownership stake disclosure by WELLINGTON MANAGEMENT GROUP LLP (amended)
WELLINGTON MANAGEMENT GROUP LLP, filed by